These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16029074)

  • 1. Review: production, characterization, and testing of banked mammalian cell substrates used to produce biological products.
    Schiff LJ
    In Vitro Cell Dev Biol Anim; 2005; 41(3-4):65-70. PubMed ID: 16029074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of animal cell substrates for biological products.
    Petricciani J; Sheets R
    Biologicals; 2008 Nov; 36(6):359-62. PubMed ID: 18674929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The preparation and validation of stock cultures of mammalian cells.
    Facklam TJ; Geyer S
    Bioprocess Technol; 1991; 13():54-85. PubMed ID: 1367151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of biotechnological products: analysis of the expression construct in cell lines used for production of r-DNA derived protein products. ICH Harmonised Tripartite Guideline.
    Dev Biol Stand; 1998; 93():205-8. PubMed ID: 9737397
    [No Abstract]   [Full Text] [Related]  

  • 5. Quality of biotechnological products: viral safety evaluation of biotechnology products derived from cell lines of human or animal origin. ICH Harmonised Tripartite Guideline.
    Dev Biol Stand; 1998; 93():177-201. PubMed ID: 9737396
    [No Abstract]   [Full Text] [Related]  

  • 6. Elimination of serum from cell culture medium.
    Lubiniecki AS
    Dev Biol Stand; 1999; 99():153-6. PubMed ID: 10404886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations. Report of the WHO Study Group on Cell Substrates for the Production of Biologicals, 22-23 April 2009, Bethesda, USA.
    Knezevic I; Stacey G; Petricciani J; Sheets R;
    Biologicals; 2010 Jan; 38(1):162-9. PubMed ID: 19818645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals (requirements for biological substances No 50).
    Dev Biol Stand; 1998; 93():141-71. PubMed ID: 9737395
    [No Abstract]   [Full Text] [Related]  

  • 9. Introduction to the issues: recently developed methods for characterizing cell lines.
    Kozak RW
    Dev Biol Stand; 1992; 76():21-4. PubMed ID: 1478337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety issues of animal products used in serum-free media.
    Merten OW
    Dev Biol Stand; 1999; 99():167-80. PubMed ID: 10404888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycoplasma testing of cell substrates and biologics: Review of alternative non-microbiological techniques.
    Volokhov DV; Graham LJ; Brorson KA; Chizhikov VE
    Mol Cell Probes; 2011; 25(2-3):69-77. PubMed ID: 21232597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals (Requirements for biological susbstances no. 50).
    Grachev V; Magrath D; Griffiths E
    Biologicals; 1998 Sep; 26(3):175-93. PubMed ID: 10208720
    [No Abstract]   [Full Text] [Related]  

  • 13. Benefits and risks due to animal serum used in cell culture production.
    Wessman SJ; Levings RL
    Dev Biol Stand; 1999; 99():3-8. PubMed ID: 10404869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality control of bovine serum used for vaccine production.
    Mareschal JC
    Dev Biol Stand; 1999; 99():61-8. PubMed ID: 10404877
    [No Abstract]   [Full Text] [Related]  

  • 15. Summary and conclusion. Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals.
    Castle P; Robertson JS
    Dev Biol Stand; 1999; 99():191-6. PubMed ID: 10404890
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell banking.
    Wiebe ME; May LH
    Bioprocess Technol; 1990; 10():147-60. PubMed ID: 1367056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine serum: reducing the variables through the use of donor herds.
    Rolleston WB
    Dev Biol Stand; 1999; 99():79-86. PubMed ID: 10404879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ICH guidelines and PhEur monographs on derivation and characterisation of cell substrates used for production of biotechnological/biological products. International Conference on Harmonisation.
    Dobbelaer R
    Dev Biol Stand; 1999; 98():159-65; discussion 167. PubMed ID: 10494969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current issues in viral assays and viral clearance evaluation.
    Lubiniecki AS
    Dev Biol Stand; 1996; 88():9-11. PubMed ID: 9119167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting viruses in sera: methods used and their merits.
    Jennings A
    Dev Biol Stand; 1999; 99():51-9. PubMed ID: 10404876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.